Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.

[1]  L. Babiuk,et al.  Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies. , 2008, Vaccine.

[2]  B. Hoffmann,et al.  A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses. , 2006, Journal of virological methods.

[3]  C. Chase,et al.  Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine. , 2006, Journal of the American Veterinary Medical Association.

[4]  John Samuel,et al.  Biodegradable nanoparticle delivery of a Th2‐biased peptide for induction of Th1 immune responses , 2006, The Journal of pharmacy and pharmacology.

[5]  S. V. D. L. D. Hurk.  Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. , 2006 .

[6]  E. Thiry,et al.  Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype. , 2006, Veterinary microbiology.

[7]  H. Shams.  Recent developments in veterinary vaccinology. , 2005, Veterinary journal.

[8]  H. Rziha,et al.  Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus , 2004, Veterinary Record.

[9]  M. Lemaire,et al.  Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field , 2003, Veterinary Record.

[10]  P. König,et al.  Markerdiagnostik in der Bekämpfung des Bovinen Herpesvirus vom Typ 1: Möglichkeiten und Grenzen , 2003 .

[11]  M. Beer,et al.  Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants. , 2003, The Journal of general virology.

[12]  L. Babiuk,et al.  Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR. , 2002, JIM - Journal of Immunological Methods.

[13]  M. Lemaire,et al.  Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies. , 2001, Vaccine.

[14]  B. Mahon.  The rational design of vaccine adjuvants for mucosal and neonatal immunization. , 2001, Current medicinal chemistry.

[15]  D. Court,et al.  A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. , 2001, Genomics.

[16]  M. D. de Jong,et al.  Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. , 2001, Vaccine.

[17]  G. Keil,et al.  Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheitis , 2000, Veterinary Record.

[18]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Hunter,et al.  Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria. , 1999, Vaccine.

[20]  J. Hage,et al.  A comparative study of serological tests for use in the bovine herpesvirus 1 eradication programme in The Netherlands. , 1998, Veterinary microbiology.

[21]  M. D. de Jong,et al.  An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. , 1998, Vaccine.

[22]  J. V. van Oirschot,et al.  An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. , 1997, Journal of virological methods.

[23]  N. Visser.  Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus. , 1997, Veterinary microbiology.

[24]  N. Osterrieder,et al.  Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. , 1997, Virology.

[25]  E. Heinen,et al.  A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. , 1996, Veterinary microbiology.

[26]  A. H. Kroese,et al.  An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. , 1996, Veterinary microbiology.

[27]  J. Stegeman,et al.  The use of marker vaccines in eradication of herpesviruses. , 1996, Journal of biotechnology.

[28]  A. Gielkens,et al.  Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. , 1996, Veterinary microbiology.

[29]  A. Stegeman.  Pseudorabies virus eradication by area-wide vaccination is feasible. , 1995, The Veterinary quarterly.

[30]  J. Glorioso,et al.  Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration , 1987, Journal of virology.

[31]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[32]  P. Nettleton,et al.  Infectious bovine rhinotracheitis virus excretion after vaccination , 1980, Veterinary Record.

[33]  Kahrs Rf.  Infectious bovine rhinotracheitis: a review and update. , 1977, Journal of the American Veterinary Medical Association.

[34]  O. Straub,et al.  [Further investigations to differentiate IBR-virus from IPV-virus by the carrier-free zone electrophoresis in a glucose density gradient]. , 1972, Archiv fur die gesamte Virusforschung.